Why Is Myobloc So Hard to Find? [Explained for 2026]

If your doctor prescribed Myobloc (rimabotulinumtoxinB) and you've been making calls trying to track it down, you're not alone. This brand-only botulinum toxin type B injection is one of the more specialized medications on the market, and finding it stocked at a nearby pharmacy can take real effort. The good news: there's no active FDA shortage of Myobloc. The challenge is structural — it's simply not the kind of drug that sits on a shelf at your local CVS.

What Is Myobloc and Why Is It Unique?

Myobloc is the only FDA-approved botulinum toxin type B product in the United States. It was first approved in December 2000 for cervical dystonia — a painful neurological condition that causes involuntary neck muscle contractions — and in 2019 received expanded approval for chronic sialorrhea (excessive drooling). It's made by Solstice Neurosciences, a subsidiary of Supernus Pharmaceuticals.

Unlike the type A botulinum toxins (Botox, Dysport, Xeomin, Daxxify), Myobloc works by cleaving a different protein — VAMP/synaptobrevin — at the neuromuscular junction. This different mechanism makes it especially valuable for patients who have developed resistance or antibodies to type A toxins. But it also means Myobloc occupies a distinct niche: it's a specialty drug prescribed by neurologists and movement disorder specialists, not a high-volume product that most pharmacies carry on demand.

Is There a Myobloc Shortage in 2026?

As of 2026, Myobloc is not listed on the FDA Drug Shortages Database as an active shortage. However, "no shortage" does not mean "easy to find." Myobloc is a brand-only specialty injectable with no generic equivalent. It requires refrigeration (2°C to 8°C), is dispensed in single-dose vials, and is typically ordered on an as-needed basis rather than kept in standing inventory at most pharmacies.

This means even when supply is normal at the distributor level, your local pharmacy may not have it in stock — and may not even carry it routinely. Patients often have to contact multiple specialty pharmacies, hospital-affiliated outpatient pharmacies, or their prescriber's office to locate a source.

Why Don't Regular Pharmacies Stock Myobloc?

Several factors make Myobloc a poor fit for typical retail pharmacy shelves:

High cost. At roughly $1,777 per 10,000-unit vial at average retail pricing, stocking Myobloc ties up significant capital.

Low prescription volume. Cervical dystonia affects an estimated 60,000–100,000 Americans. Myobloc's patient population is even smaller — primarily those unresponsive or intolerant to type A toxins.

Cold chain requirements. Myobloc must be stored refrigerated at 36°F–46°F and must NOT be frozen or shaken. These requirements add logistics complexity.

Provider-administered. In many cases, Myobloc is purchased and administered directly by the physician's office or hospital clinic — meaning patients never pick it up at a pharmacy at all.

Insurance step therapy. Most insurers require patients to try and fail type A botulinum toxins (Botox, Dysport, Xeomin) before authorizing Myobloc, keeping its covered patient volume lower.

Who Typically Has Myobloc in Stock?

The most reliable places to find Myobloc include:

Specialty pharmacies that dispense injectable biologics and maintain cold chain handling

Hospital outpatient pharmacies affiliated with neurology or movement disorder programs

The prescribing neurologist's office (many movement disorder specialists stock Myobloc directly)

Large independent pharmacies with specialty drug programs

How Insurance Affects Myobloc Access

Myobloc is notably not covered by Medicare. For commercial insurance, prior authorization is required by virtually all plans. Most insurers — including Aetna, Cigna, and Blue Cross Blue Shield — classify Myobloc as a non-preferred agent and require documented trial and failure of at least one (and often all) type A botulinum toxins before Myobloc will be authorized. This step therapy creates additional delays in access for new patients.

If you're commercially insured and newly prescribed Myobloc, expect the prior authorization process to take 1–4 weeks. Work with your neurologist's office — many have staff experienced in obtaining PA approvals for botulinum toxins.

What If You Can't Find Myobloc?

If Myobloc genuinely isn't available in your area, talk to your neurologist. For cervical dystonia, the type A toxins (Botox, Dysport, Xeomin, Daxxify) are approved alternatives — though if you're specifically on Myobloc because you've developed resistance to type A products, this may not be a viable substitute. Your doctor can help assess whether a therapeutic alternative makes sense for your situation.

For a full breakdown of botulinum toxin alternatives, see our guide: Alternatives to Myobloc if you can't fill your prescription.

How medfinder Can Help

Rather than calling specialty pharmacies yourself, medfinder can do that work for you. You provide your medication, dosage, and location — medfinder calls pharmacies on your behalf to check who has Myobloc in stock, then texts you the results. It saves you the time and frustration of making calls on your own.

For step-by-step tips on tracking down Myobloc, see our related guide: How to Find Myobloc in Stock Near You.